IAF (Alexander Fleming Institute)

What IAF (Alexander Fleming Institute) does

Instituto Alexander Fleming (IAF) is a private oncology institute headquartered in Colegiales, Buenos Aires, Argentina, founded on March 14, 1994. It was the first private oncology institute established in Latin America and operates five physical locations across the Buenos Aires metropolitan area, including a dedicated skin oncology unit (UOC), a Saavedra branch, a Palermo site within the Swiss Medical Center, and a Ramos Mejía location operated through a partnership with DIM Alta Complejidad. The institute serves cancer patients and the broader oncology ecosystem, providing prevention, screening, diagnosis, treatment, and follow-up services through over 50 medical specialties and a network of more than 500 medical specialists.

The institute's clinical and technical infrastructure spans high-complexity modalities including PET/CT and SPECT nuclear medicine, MRI-guided interventions, radiotherapy, immunotherapy, chemotherapy in a dedicated day hospital, and a hematopoietic stem cell transplant program accredited by the U.S. National Marrow Donor Program (NMDP) for unrelated-donor bone marrow transplants. Diagnostic and translational capabilities are anchored by clinical analysis, immunohistochemistry, and pathological anatomy laboratories, plus a Centro Genético for hereditary cancer risk assessment and counseling. Research is conducted through the Centro de Investigaciones Oncológicas (CIO) under a cooperation agreement with Fundación Cáncer / Fundación Uhría, with active programs in anti-tumor vaccines, dendritic cell vaccine technology (using apoptotic tumor cells for antigen presentation), and genomic and proteomic biomarker identification (laser microdissection and protein microarrays) in melanoma and colorectal cancer. Phase I trial outcomes reported include 100% disease-free status at four years for stage IIB melanoma patients and 80% preventive efficacy in preclinical dendritic cell vaccine studies.

IAF monetizes through fee-for-service medical care delivered under three revenue streams: direct medical services (consultations, imaging, radiotherapy, chemotherapy, hospitalization, surgery), billings to more than 40 health insurance and prepaid medicine providers including Swiss Medical Group, AVALIAN, APSOT, OSPE, and BUPASeguro, and out-of-pocket payments from uninsured patients. Distribution is omnichannel across physical sites, a 24-hour medical emergency service, a home care program (IAF a tu domicilio), a digital patient portal (Mi Portal), and direct appointment booking via WhatsApp and phone. The institution is a privately held Argentine corporation (Alexander Fleming S.A.) with no disclosed external shareholders, parent company, or funding rounds.

Name

IAF (Alexander Fleming Institute)

Legal name

Alexander Fleming S.A.

Website

https://alexanderfleming.org

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

Instituto Alexander Fleming (IAF) is a private oncology institute in Buenos Aires, Argentina, providing comprehensive cancer care—from prevention and diagnosis through treatment and follow-up—across 50+ specialties with 500+ medical specialists at five locations.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Ambulatory Health Care Services (621), Offices of Physicians (62111), Diagnostic Imaging Centers (621512), Medical and Diagnostic Laboratories (62151)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Thoracic (Lung) Oncology (HLAKAFAL), Gastrointestinal Oncology (HLAKAFAK)

Keywords

• Oncology services
• Cancer treatment
• Medical imaging
• Bone marrow transplant
• Radiation therapy

Headquarters

HQ city

Buenos Aires

HQ country

Argentina

HQ region

Latin America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from comprehensive oncology healthcare services including consultations, diagnostic tests, treatments, hospitalizations, surgeries, radiotherapy, and chemotherapy administered to patients through the institute's facilities.
2. Health Insurance Billings: Services billed through multiple health insurance providers (obra social/prepaga) including AVALIAN, APSOT, Swiss Medical Group, OSPE, BUPASeguro, and over 40 other providers listed.
3. Private Pay Patients: Direct payment from patients without insurance coverage for medical services.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Instituto Alexander Fleming (IAF) is a private oncology institute providing comprehensive cancer prevention, diagnosis, treatment, and follow-up services. Its offerings include specialized oncology units (breast, skin, hematology/bone marrow transplant), advanced diagnostic imaging and nuclear medicine, radiotherapy, chemotherapy, immunotherapy, genetic counseling, psycho-oncology support, and home healthcare services delivered across multiple Buenos Aires locations and through digital patient portals.

Product overview

Instituto Alexander Fleming (IAF) is a private oncology institute in Argentina offering comprehensive cancer care through an integrated platform of specialized medical centers, diagnostic services, treatment units, and support programs. The core offerings include specialized oncology centers (Centro Mamario for breast cancer, Unidad de Oncología Cutánea for skin cancer, Hematología y UTH for bone marrow transplants), advanced diagnostic services (Diagnóstico por Imágenes, Medicina Nuclear, Laboratories), and treatment programs (Radioterapia, Hospital de Día for chemotherapy/immunotherapy). The institute also provides patient-centered programs like One Day de la Mujer and One Day MAMOx for rapid diagnosis, Onco 360 for integrated care coordination, and Mi Portal for digital patient access. A dedicated Centro Genético provides hereditary cancer risk assessment, while psycho-oncology and home care services round out the comprehensive care ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

• CIO - Centro de Investigaciones Oncológicas: Oncology research center operating under a cooperation agreement with Fundación Cáncer, focused on tumor vaccines and cancer immunology.
• CEIAF
• Centro Mamario Alexander Fleming
• Onco 360
• One Day de la Mujer
• One Day MAMOx

Products and services

• Centro Mamario Alexander Fleming
• Unidad de Oncología Cutánea (U.O.C)
• Hematología y Unidad de Trasplante Hematopoyético (UTH)
• Diagnóstico por Imágenes
• Medicina Nuclear
• Radioterapia
• Hospital de Día
• Laboratorio de Análisis Clínicos
• Centro Genético
• Onco 360
• Guardia Médica 24 hs
• IAF a tu Domicilio
• One Day MAMOx
• One Day de la Mujer
• Psico-Oncología: Espacio para el Bienestar
• Cirugías
• Anatomía Patológica
• Laboratorio de Inmunohistoquímica
• Consultorio de Asesoramiento Genético en Oncología
• Programa de Evaluación Prequirúrgica (PEP)
• Programa de Salud Pulmonar (PSP)
• Internación
• Consultorios
• Cardiología
• Servicio de Hemoterapia

Quantifiable outcome

• 100% of stage IIB melanoma patients disease-free at 4 years post-surgery in Phase I vaccine trial
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• DIM Alta ComplejidadcoreStrategic or Co-development Partner · 23 October 2023Strategic alliance between Instituto Alexander Fleming and DIM Alta Complejidad in Ramos Mejía, bringing international quality medical standards to the Western Zone of Greater Buenos Aires. The partnership offers preventive health screenings, first-level oncologists, and second opinions under IAF's renowned medical reputation combined with DIM's established presence in the area.
• Fundación Alexander FlemingcoreStrategic or Co-development PartnerThe Alexander Fleming Foundation supports the institute's mission in oncology research and patient care, likely involved in funding research initiatives and community outreach programs.
• CIO-FUCA (Centro de Investigaciones Oncológicas - Fundación Uhría)coreStrategic or Co-development PartnerResearch partnership with the Centro de Investigaciones Oncológicas affiliated with Fundación Uhría, conducting anti-tumor vaccine research, dendritic cell vaccine development, and genomic/proteomic studies in colorectal cancer.
• N.M.D.P. (National Marrow Donor Program)coreStrategic or Co-development PartnerFirst Argentine institution accredited by the U.S. National Marrow Donor Program for performing unrelated bone marrow transplants, enabling international stem cell donor matching.

Scale indicators5 records

Recent moves1 record

Direct peers

• Hospital Italiano de Buenos Aires: One of the largest private academic medical centers in Buenos Aires, offering comprehensive oncology, hematology, imaging, and transplant services. Directly comparable as a Buenos Aires-based private hospital competing for the same oncology patient population and insurance networks.
• Hospital Británico de Buenos Aires: Major Buenos Aires private hospital with oncology, imaging, and hematology services. IAF-affiliated physicians cross-credential here, indicating overlapping clinical talent and direct competition for the same private-payer oncology patients.
• Hospital Alemán de Buenos Aires: Large Buenos Aires private general hospital with oncology and diagnostic capabilities. Comparable as a competing private hospital system offering multidisciplinary cancer care within the same metropolitan insurance market.
• Hospital Universitario Austral: Buenos Aires-area private academic hospital affiliated with Universidad Austral, offering oncology, imaging, and hematology services. Comparable as a competing premium private hospital with multi-specialty cancer programs.
• FLENI: Argentine specialty hospital renowned for neurology/neurosurgery, with growing oncology and advanced imaging capabilities. Comparable as a single-specialty-turned-integrated private institution with research arm and premium positioning.
• Sanatorio Güemes: Large Buenos Aires private hospital with oncology, radiotherapy, and hematology services. Directly comparable as a competing private institution serving the same obra social/prepaga patient base.
• A.C. Camargo Cancer Center: One of Latin America's largest dedicated cancer centers, based in São Paulo. Comparable as a specialty oncology hospital with research, genomic, and transplant services targeting similar private-pay and insured oncology patients in the region.

Regional players

• Hospital Privado Universitario de Córdoba: Major Argentine private academic hospital outside Buenos Aires with oncology, hematology, and bone marrow transplant services. Comparable as a private specialty hospital model within Argentina, but does not directly compete in the Buenos Aires metro.
• INEN (Instituto Nacional de Enfermedades Neoplásicas): Peruvian public reference cancer hospital offering comprehensive oncology, hematology, and bone marrow transplant services. Comparable as a leading specialty oncology center in Latin America but serves a different country/payer system.

Emerging players

• Oncoclínicas Group: Brazilian oncology clinic and hospital network offering specialized cancer care across multiple sites. Comparable as a multi-site private oncology provider model expanding across a Latin American market.

Market position

Strengths5 records

Weaknesses5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/iaf_fleming
• YouTubeyoutube.com/@alexanderfleming1786/videos
• Facebookfacebook.com/alexanderflemingsa
• LinkedInlinkedin.com/company/institutooncológicoalexanderfleming
• Instagraminstagram.com/institutoalexanderfleming

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IAF (Alexander Fleming Institute)